Global Cell and Gene Therapy Manufacturing Services Market to 2028, Led by Catalent, Lonza, Merck KGaA, and Thermo Fisher Scientific ...Middle East

PR Newswire - News
Global Cell and Gene Therapy Manufacturing Services Market to 2028, Led by Catalent, Lonza, Merck KGaA, and Thermo Fisher Scientific
DUBLIN, July 26, 2023 /PRNewswire/ -- The "Cell and Gene Therapy Manufacturing Services Market" report has been added to ResearchAndMarkets.com's offering. The global market for cell and gene therapy manufacturing services was estimated to be $4.9 billion in 2022 and is expected to...

Hence then, the article about global cell and gene therapy manufacturing services market to 2028 led by catalent lonza merck kgaa and thermo fisher scientific was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Global Cell and Gene Therapy Manufacturing Services Market to 2028, Led by Catalent, Lonza, Merck KGaA, and Thermo Fisher Scientific )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News